A man in Scotland whose hands were left unusable by scleroderma has been given a new lease of life after what is believed to be the world’s first double hand transplant for the condition. Steven ...

IFLScience needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time.

Pivotal trial to support marketing approval of regenerative cells processed with the Celution® System to commence in Q2 2022 SAN DIEGO--(BUSINESS WIRE)--Paracrine, Inc. announced today that the FDA ...

Please provide your email address to receive an email when new articles are posted on . Rheumatologists are likely to be at the “forefront” of diagnosing scleroderma skin disorders and other ...

48-year-old Steven Gallagher is thought to be the first person to get a double hand transplant to help with his scleroderma. Reading time 2 minutes A man in the UK appears to be the first person to ...

A dad who lost the use of his hands to a rare disease has had them replaced in a world-first operation. Steven Gallagher, 48, suffered scleroderma, a condition where the skin hardens and tightens. He ...

SAN DIEGO--(BUSINESS WIRE)--Paracrine, Inc., announced today the online publication (ahead of print) of the findings from the STAR I trial in Arthritis & Rheumatology Journal, the official journal of ...

Please provide your email address to receive an email when new articles are posted on . The last 3 years of drug development in scleroderma have come to represent everything that ails the current ...

A man whose hands were left unusable by scleroderma has been given a new lease of life after what is believed to be the world’s first double hand transplant for the condition. Steven Gallagher, 48, ...